Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Lodde

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
BJU International|February 9, 2012
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Thomas Martini, et al.
Urology|September 19, 2013
Cytology as an alternative to frozen section at the time of nephron-sparing surgery to evaluate surgical margin statusSalvatore M Palermo, Christopher Dechet, Emanuela Trenti, et al.
European Urology|April 27, 2012
Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Mattias May, Thomas Martini, et al.
Urologic Oncology|March 16, 2019
Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric seriesMaximilian Haider, Christian Ladurner, Roman Mayr, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2016
Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based studyAnnalisa Trama, Laura Botta, Nicola Nicolai, et al.
Cancer Medicine|October 3, 2023
Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trialJosée Savard, Hanane Moussa, Jean-François Pelletier, et al.
Urologia Internationalis|August 21, 2014
The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Maximilian Burger, et al.
BJU International|October 4, 2017
Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitorsVincent Fradet, Paul Toren, Molière Nguile-Makao, et al.
Urologia Internationalis|June 28, 2014
Comparison of complications from radical cystectomy between old-old versus oldest-old patientsEvi Comploj, Jeremy West, Michael Mian, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 22, 2021
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphySamuel Otis-Chapados, Cassandra Ringuette Goulet, Gabriel Dubois, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
BJU International|February 9, 2012
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Thomas Martini, et al.
Urology|September 19, 2013
Cytology as an alternative to frozen section at the time of nephron-sparing surgery to evaluate surgical margin statusSalvatore M Palermo, Christopher Dechet, Emanuela Trenti, et al.
European Urology|April 27, 2012
Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Mattias May, Thomas Martini, et al.
Urologic Oncology|March 16, 2019
Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric seriesMaximilian Haider, Christian Ladurner, Roman Mayr, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2016
Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based studyAnnalisa Trama, Laura Botta, Nicola Nicolai, et al.
Cancer Medicine|October 3, 2023
Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trialJosée Savard, Hanane Moussa, Jean-François Pelletier, et al.
Urologia Internationalis|August 21, 2014
The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Maximilian Burger, et al.
BJU International|October 4, 2017
Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitorsVincent Fradet, Paul Toren, Molière Nguile-Makao, et al.
Urologia Internationalis|June 28, 2014
Comparison of complications from radical cystectomy between old-old versus oldest-old patientsEvi Comploj, Jeremy West, Michael Mian, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 22, 2021
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphySamuel Otis-Chapados, Cassandra Ringuette Goulet, Gabriel Dubois, et al.
Pageof 7